Key Insights

Highlights

Success Rate

57% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

3 terminated out of 12 trials

Success Rate

57.1%

-29.4% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results57% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (8)
P 2 (1)
P 4 (1)

Trial Status

Completed4
Unknown4
Terminated3
Active Not Recruiting1

Trial Success Rate

57.1%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (12)

Research Network

Activity Timeline